Relx Plc (NYSE:RELX) Shares Sold by Clarius Group LLC

Clarius Group LLC lowered its position in shares of Relx Plc (NYSE:RELX) by 7.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 7,862 shares of the technology company’s stock after selling 597 shares during the quarter. Clarius Group LLC’s holdings in Relx were worth $357,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in RELX. Rhumbline Advisers lifted its stake in shares of Relx by 8.8% in the second quarter. Rhumbline Advisers now owns 30,808 shares of the technology company’s stock worth $1,413,000 after buying an additional 2,479 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in Relx by 6.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 2,967,642 shares of the technology company’s stock valued at $136,155,000 after acquiring an additional 169,284 shares during the last quarter. Benjamin F. Edwards & Company Inc. lifted its stake in Relx by 5.7% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 7,422 shares of the technology company’s stock worth $341,000 after purchasing an additional 403 shares in the last quarter. Profund Advisors LLC boosted its holdings in shares of Relx by 3.0% during the 2nd quarter. Profund Advisors LLC now owns 14,007 shares of the technology company’s stock worth $643,000 after purchasing an additional 407 shares during the last quarter. Finally, Frank Rimerman Advisors LLC purchased a new stake in shares of Relx in the second quarter valued at approximately $470,000. Institutional investors and hedge funds own 15.02% of the company’s stock.

Relx Stock Performance

Shares of NYSE RELX opened at $48.18 on Monday. The company has a 50 day simple moving average of $46.44 and a 200-day simple moving average of $46.59. Relx Plc has a 1 year low of $40.25 and a 1 year high of $48.91.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on RELX shares. StockNews.com started coverage on Relx in a research note on Wednesday, October 30th. They set a “hold” rating on the stock. Redburn Atlantic began coverage on shares of Relx in a research report on Wednesday, January 8th. They set a “buy” rating on the stock.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.